Doliracetam
Jump to navigation
Jump to search
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C16H14N2O2 |
Molar mass | 266.300 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Doliracetam is a nootropic drug (cognition enhancer) from the racetam family used in treatment of epilepsy.[1][2]
According to the Hoechst patent title, it has neuroanabolic action.
See also
References
- ^ EP 62887, Kuch, Heinz & Kruse, Hansjörg, "Indolinone-2 derivatives, process for their preparation and neuro-anabolic mediums containing them", published 1982-10-20, assigned to Hoechst AG
- ^ Fariello RG, Ghelardini C, Di Cesare Mannelli L, Bonanno G, Pittaluga A, Milanese M, Misiano P, Farina C (June 2014). "Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain". Neuropharmacology. 81: 85–94. doi:10.1016/j.neuropharm.2014.01.029. PMID 24486381. S2CID 28039482.
Categories:
- Articles with short description
- Short description matches Wikidata
- Drugs not assigned an ATC code
- Drugs with non-standard legal status
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- Articles with changed InChI identifier
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugboxes which contain changes to verified fields
- Racetams
- Acetamides
- Indolines
- Lactams
- Oxindoles
- All stub articles
- Nervous system drug stubs